Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08877_nanopub.RA8A7vM7b00II2ROKQkd_V4hK48-e0Bj_APSoPvaFYsLM#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB08877 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08877 label "Ruxolitinib [drugbank:DB08877]" assertion.
- drugbank:DB08877 seeAlso jakafi-drug.htm assertion.
- drugbank:DB08877 seeAlso ruxolitinib.html assertion.
- drugbank:DB08877 seeAlso DB08877 assertion.
- drugbank:DB08877 description "Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. FDA approved on November 16, 2011." assertion.
- drugbank:DB08877 identifier "drugbank:DB08877" assertion.
- drugbank:DB08877 title "Ruxolitinib" assertion.
- drugbank:DB08877 drugbank_vocabulary:x-cas cas:941678-49-5 assertion.
- drugbank:DB08877 drugbank_vocabulary:drugbank-id "DB08877" assertion.
- drugbank:DB08877 bio2rdf_vocabulary:x-identifiers.org DB08877 assertion.
- drugbank:DB08877 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08877" assertion.
- drugbank:DB08877 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08877 bio2rdf_vocabulary:identifier "DB08877" assertion.
- drugbank:DB08877 drugbank_vocabulary:x-wikipedia wikipedia:Ruxolitinib assertion.
- drugbank:DB08877 drugbank_vocabulary:x-kegg kegg:D09959 assertion.
- drugbank:DB08877 drugbank_vocabulary:x-chebi chebi:66919 assertion.
- drugbank:DB08877 drugbank_vocabulary:x-atc atc:L01XE18 assertion.
- drugbank:DB08877 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB08877 drugbank_vocabulary:x-ndc ndc:50881-025-60 assertion.